FELODIPINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Felodipine, and what generic alternatives are available?
Felodipine is a drug marketed by Aurobindo Pharma Ltd, Endo Operations, Glenmark Pharms Ltd, Heritage, Jubilant Generics, Mylan, Orbion Pharms, Sun Pharm Inds Ltd, Sun Pharm Industries, Torrent Pharms Ltd, Wockhardt, Yiling, and Yung Shin Pharm. and is included in thirteen NDAs.
The generic ingredient in FELODIPINE is felodipine. There are seventeen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the felodipine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Felodipine
A generic version of FELODIPINE was approved as felodipine by GLENMARK PHARMS LTD on December 17th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FELODIPINE?
- What are the global sales for FELODIPINE?
- What is Average Wholesale Price for FELODIPINE?
Summary for FELODIPINE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Clinical Trials: | 20 |
| Patent Applications: | 4,080 |
| Drug Prices: | Drug price information for FELODIPINE |
| Drug Sales Revenues: | Drug sales revenues for FELODIPINE |
| DailyMed Link: | FELODIPINE at DailyMed |
See drug prices for FELODIPINE
Recent Clinical Trials for FELODIPINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Guangzhou Kangqi Medical Technology Co., LTD | Phase 1 |
| Overseas Pharmaceuticals, Ltd. | Phase 1 |
| Menarini International Operations Luxembourg SA | Phase 4 |
Pharmacology for FELODIPINE
| Drug Class | Dihydropyridine Calcium Channel Blocker |
| Mechanism of Action | Calcium Channel Antagonists |
Medical Subject Heading (MeSH) Categories for FELODIPINE
Anatomical Therapeutic Chemical (ATC) Classes for FELODIPINE
US Patents and Regulatory Information for FELODIPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wockhardt | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 091484-002 | Aug 15, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Torrent Pharms Ltd | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 202170-001 | Nov 28, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Wockhardt | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 091484-003 | Aug 15, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Torrent Pharms Ltd | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 202170-002 | Nov 28, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
